MAXCYTE, INC.·4

Dec 1, 4:43 PM ET

BALTHROP PATRICK J 4

4 · MAXCYTE, INC. · Filed Dec 1, 2022

Insider Transaction Report

Form 4
Period: 2022-11-30
Transactions
  • Award

    Stock Option (right to buy)

    2022-11-30+100,000100,000 total
    Exercise: $5.99Exp: 2032-11-29Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. 1/3rd of the shares underlying this option vest on November 30, 2023 and the remaining 2/3rds vest in 24 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer as of each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION